检验医学 ›› 2023, Vol. 38 ›› Issue (8): 796-799.DOI: 10.3969/j.issn.1673-8640.2023.08.017
收稿日期:
2021-09-17
修回日期:
2022-10-30
出版日期:
2023-08-30
发布日期:
2023-10-30
通讯作者:
陈水平,E-mail:shpchen@hotmail.com。
作者简介:
方文东,男,1996年生,学士,主要从事细菌耐药机制研究。
基金资助:
FANG Wendong1, WANG Youliang2, CHEN Shuiping3()
Received:
2021-09-17
Revised:
2022-10-30
Online:
2023-08-30
Published:
2023-10-30
摘要:
近年来,免疫抑制和危重患者IFD发生率持续上升。早期诊断IFD对降低患者死亡率、改善预后具有十分重要的意义。G试验是早期诊断侵袭性真菌病(IFD)重要的血清学方法之一,目前已广泛应用于临床。然而,医源性污染、细菌感染、肠道黏膜受损会导致G试验结果假阳性;抗真菌药物治疗、突破性念珠菌感染等会导致G试验结果假阴性。文章对G试验的影响因素进行综述,以帮助临床和实验室正确根据G试验结果及时制定相应的治疗策略。
中图分类号:
方文东, 王友亮, 陈水平. G试验影响因素分析[J]. 检验医学, 2023, 38(8): 796-799.
FANG Wendong, WANG Youliang, CHEN Shuiping. Analysis on influencing factors of G assay[J]. Laboratory Medicine, 2023, 38(8): 796-799.
[1] |
PERSON A K, KONTOYIANNIS D P, ALEXANDER B D. Fungal infections in transplant and oncology patients[J]. Hematol Oncol Clin North Am, 2011, 25(1):193-213.
DOI URL |
[2] | BARTON R C. Laboratory diagnosis of invasive aspergillosi:from diagnosis to prediction of outcome[J]. Scientifica(Cairo), 2013, 2013:459405. |
[3] |
DE PAUW B, WALSH T J, DONNELLY J P, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases Mycoses Study Group(EORTC/MSG)consensus group[J]. Clin Infect Dis, 2008, 46(12):1813-1821.
DOI URL |
[4] |
TALENTO A F, DUNNE K, JOYCE E A, et al. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit[J]. J Crit Care, 2017, 40:119-127.
DOI PMID |
[5] |
ROSE S R, VALLABHAJOSYULA S, VELEZ M G, et al. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections[J]. J Infect, 2014, 69(3):278-283.
DOI PMID |
[6] |
RHEIN J, BAHR N C, MORAWSKI B M, et al. Detection of high cerebrospinal fluid levels of(1→3)-β-D-glucan in cryptococcal meningitis[J]. Open Forum Infect Dis, 2014, 1(3):ofu105.
DOI URL |
[7] |
KARAGEORGOPOULOS D E, VOULOUMANOU E K, NTZIORA F, et al. β-D-glucan assay for the diagnosis of invasive fungal infections:a meta-analysis[J]. Clin Infect Dis, 2011, 52(6):750-770.
DOI URL |
[8] | FINKELMAN M A. Specificity influences in(1→3)-β-D-glucan-supported diagnosis of invasive fungal disease[J]. J Fungi(Basel), 2020, 7(1):14. |
[9] |
LISS B, CORNELY O A, HOFFMANN D, et al. 1,3-β-D-glucan contamination of common antimicrobials[J]. J Antimicrob Chemother, 2016, 71(4):913-915.
DOI PMID |
[10] |
MARTY F M, LOWRY C M, LEMPITSKI S J, et al. Reactivity of(1→3)-β-D-glucan assay with commonly used intravenous antimicrobials[J]. Antimicrob Agents Chemother, 2006, 50(10):3450-3453.
DOI URL |
[11] |
MENNINK-KERSTEN M A, WARRIS A, VERWEIJ P E. 1,3-β-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid[J]. N Engl J Med, 2006, 354(26):2834-2835.
DOI URL |
[12] |
RACIL Z, KOCMANOVA I, LENGEROVA M, et al. Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis[J]. J Med Microbiol, 2010, 59(9):1016-1022.
DOI URL |
[13] |
METAN G, AGKUS C, NEDRET K A, et al. Does ampicillin-sulbactam cause false positivity of(1,3)-beta-D-glucan assay?A prospective evaluation of 15 patients without invasive fungal infections[J]. Mycoses, 2012, 55(4):366-371.
DOI URL |
[14] |
ISHIZUKA Y, TSUKADA H, GEJYO F. Interference of(1→3)-β-D-glucan administration in the measurement of plasma(1→3)-β-D-glucan[J]. Intern Med, 2004, 43(2):97-101.
DOI URL |
[15] |
SCHROEDER I, DICHTL K, LIEBCHEN U, et al. Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patients[J]. Infection, 2021, 49(2):241-248.
DOI |
[16] |
LISS B, CORNELY O A, HOFFMANN D, et al. 1,3-β-D-glucan concentrations in blood products predict false positive post-transfusion results[J]. Mycoses, 2016, 59(1):39-42.
DOI URL |
[17] |
BOUGNOUX M E, ANGEBAULT C, PACCOUD O, et al. Impact of intravenous and subcutaneous immunoglobulins on false positivity of galactomannan and β-D-glucan antigenaemia and detection of circulating Aspergillus fumigatus DNA[J]. Clin Microbiol Infect, 2020, 26(8):1101-1102.
DOI URL |
[18] |
EGGER M, PRÜLLER F, RAGGAM R, et al. False positive serum levels of(1-3)-β-D-glucan after infusion of intravenous immunoglobulins and time to normalisation[J]. J Infect, 2018, 76(2):206-210.
DOI URL |
[19] |
KANDA H, KUBO K, HAMASAKI K, et al. Influence of various hemodialysis membranes on the plasma(1→3)-beta-D-glucan level[J]. Kidney Int, 2001, 60(1):319-323.
DOI URL |
[20] |
PRATTES J, SCHNEDITZ D, PRÜLLER F, et al. 1,3-β-D-glucan testing is highly specific in patients undergoing dialysis treatment[J]. J Infect, 2017, 74(1):72-80.
DOI URL |
[21] |
VIGOR K, EMERSON J, SCOTT R, et al. Development of downstream processing to minimize beta-glucan impurities in GMP-manufactured therapeutic antibodies[J]. Biotechnol Prog, 2016, 32(6):1494-1502.
DOI URL |
[22] |
KANAMORI H, KANEMITSU K, MIYASAKA T, et al.Measurement of(1-3)-β-D-glucan derived from different gauze types[J]. Tohoku J Exp Med, 2009, 217(2):117-121.
DOI URL |
[23] |
SZYSZKOWITZ A, ZURL C, HERZEG A, et al. Serum 1,3-beta-D-glucan values during and after laparoscopic and open intestinal surgery[J]. Open Forum Infect Dis, 2018, 5(12):ofy296.
DOI URL |
[24] |
SHUPP J W, PETRAITIENE R, JASKILLE A D, et al. Early serum(1→3)-β-D-glucan levels in patients with burn injury[J]. Mycoses, 2012, 55(3):224-227.
DOI URL |
[25] |
MENNINK-KERSTEN M A, VERWEIJ P E. Non-culture-based diagnostics for opportunistic fungi[J]. Infect Dis Clin North Am, 2006, 20(3):711-727.
DOI URL |
[26] | LEQUETTE Y, ROLLET E, DELANGLE A, et al. Linear osmoregulated periplasmic glucans are encoded by the opgGH locus of Pseudomonas aeruginosa[J]. Microbiology(Reading), 2007, 153(Pt 10):3255-3263. |
[27] |
KOYA J, NANNYA Y, KOBAYASHI H, et al. Simultaneous increase in 1,3-β-D-glucan and procalcitonin levels in Pseudomonas aeruginosa infection[J]. J Infect, 2013, 67(2):164-166.
DOI URL |
[28] |
ALBERT O, TOUBAS D, STRADY C, et al. Reactivity of(1→3)-β-D-glucan assay in bacterial bloodstream infections[J]. Eur J Clin Microbiol Infect Dis, 2011, 30(11):1453-1460.
DOI URL |
[29] |
SAWAI T, NAKAO T, YAMAGUCHI S, et al. Detection of high serum levels of β-D-glucan in disseminated nocardial infection:a case report[J]. BMC Infect Dis, 2017, 17(1):272.
DOI URL |
[30] |
LEELAHAVANICHKUL A, WORASILCHAI N, WANNALERDSAKUN S, et al. Gastrointestinal leakage detected by serum(1→3)-β-D-glucan in mouse models and a pilot study in patients with sepsis[J]. Shock, 2016, 46(5):506-518.
DOI URL |
[31] |
ISSARA-AMPHORN J, SURAWUT S, WORASILCHAI N, et al. The synergy of endotoxin and(1→3)-β-D-glucan,from gut translocation,worsens sepsis severity in a lupus model of Fc gamma receptor,Ⅱb-deficient mice[J]. J Innate Immun, 2018, 10(3):189-201.
DOI URL |
[32] | HASHIMOTO N, MORI T, HASHIDA R, et al. False-positive serum(1,3)-β-D-glucan elevation due to intake of seaweed in a hematopoietic stem cell transplant recipient[J]. Transpl Infect Dis, 2017, 19(2). |
[33] |
ELIZAQUÍVEL P, SÁNCHEZ G, SALVADOR A, et al. Evaluation of yogurt and various beverages as carriers of lactic acid bacteria producing 2-branched(1,3)-β-D-glucan[J]. J Dairy Sci, 2011, 94(7):3271-3278.
DOI URL |
[34] |
PICKERING J W, SANT H W, BOWLES C A, et al.Evaluation of a(1→3)-β-D-glucan assay for diagnosis of invasive fungal infections[J]. J Clin Microbiol, 2005, 43(12):5957-5962.
DOI URL |
[35] |
CURTO M Á, BUTASSI E, RIBAS J C, et al. Natural products targeting the synthesis of β(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings[J]. Phytomedicine, 2021, 88:153556.
DOI URL |
[36] |
ABE M, KIMURA M, ARAOKA H, et al. Serum(1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia[J]. Med Mycol, 2014, 52(8):835-840.
DOI URL |
[37] |
PICKERING J W, SANT H W, BOWLES C A, et al. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections[J]. J Clin Microbiol, 2005, 43(12):5957-5962.
DOI URL |
[1] | 李梁珊, 赵虎, 王诗雯. 基于加权基因共表达网络分析筛选结直肠癌潜在的预后生物标志物[J]. 检验医学, 2023, 38(9): 825-832. |
[2] | 杨玉强, 全晓丽, 王刘玉, 鲜文峰, 杨红. 骨肉瘤组织RRBP1表达及其对细胞生物学特征的影响[J]. 检验医学, 2023, 38(9): 842-848. |
[3] | 赵沱, 白鹏飞, 孙婧, 程涛. 血清lncRNA NEAT1在急性心肌梗死患者中的表达及其临床意义[J]. 检验医学, 2023, 38(9): 897-900. |
[4] | 贺龙, 王莎, 程利萍, 廖子蔚, 王东红. 血清AChE、IL-17与单纯疱疹病毒性脑炎患者认知功能障碍的相关性[J]. 检验医学, 2023, 38(8): 719-724. |
[5] | 赵静, 李永勤, 李艳, 范伟光, 杨学刚. HIV/AIDS合并机会性感染患者IP-10、SAA、hs-CRP、PCT、CD4+ T细胞计数检测的意义[J]. 检验医学, 2023, 38(8): 725-729. |
[6] | 丁肖媛, 戴劲盛, 焦荣红, 马素丽, 朱海峰, 吴梦雅, 车艳然, 张蕾. 肥胖/超重对哮喘发作期患儿Th1/Th2和Th17/Treg细胞因子的影响[J]. 检验医学, 2023, 38(8): 748-752. |
[7] | 陈颖, 李伟, 林涛, 杨丽. PFTK1表达与非小细胞肺癌微血管密度和患者预后的关系[J]. 检验医学, 2023, 38(7): 634-639. |
[8] | 张旭明, 尹伟明, 高婧. 深圳市宝安地区妊娠期甲状腺功能减退患者UGT1A1基因多态性与妊娠期合并症和不良妊娠结局的关系[J]. 检验医学, 2023, 38(7): 665-668. |
[9] | 杜晶辉, 贺鑫, 刘晶, 刘瑞岩, 鲍志军, 王俊, 赵岩, 雷曜荣, 刘旻, 刘旭. 新型冠状病毒核酸检测7种振荡混匀方法效果评价[J]. 检验医学, 2023, 38(7): 680-685. |
[10] | 黄一后, 张磊, 叶志成, 成方颖. CK-MB/CK比值鉴别儿童CK-MB活性法检测假性升高[J]. 检验医学, 2023, 38(6): 538-542. |
[11] | 张莹, 景丽娟, 李丽. HBV携带者外周血单个核细胞miR-138表达与病毒增殖的关系[J]. 检验医学, 2023, 38(6): 559-562. |
[12] | 苏曦, 周琰, 黄剑, 高姚怡, 李懿皞, 王蓓丽, 潘柏申, 郭玮. CYP3A4 *1G多态性对行腹腔镜结肠癌根治术患者芬太尼剂量的影响[J]. 检验医学, 2023, 38(5): 419-423. |
[13] | 涂凡, 陈丽艳, 刘君, 翟桦梓, 芮小红, 彭燕. 非结核分枝杆菌污染摊片机致临床样本镜检结果假阳性分析[J]. 检验医学, 2023, 38(5): 494-496. |
[14] | 江梦颖, 刘鷖雯, 何怡青, 许静, 杨翠霞, 高锋, 杜艳. 血清S1P检测在结直肠癌早期诊断中的临床价值[J]. 检验医学, 2023, 38(4): 307-312. |
[15] | 张国良, 刘鷖雯, 何怡青, 许静, 杨翠霞, 高锋, 刘华. 血清HYAL1、HA在结直肠癌辅助诊断和疗效监测中的价值[J]. 检验医学, 2023, 38(4): 313-319. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||